FIT Board Review Corner April 2017

Size: px
Start display at page:

Download "FIT Board Review Corner April 2017"

Transcription

1 FIT Board Review Corner April 2017 Welcome to the FIT Board Review Corner, prepared by Tammy Peng, MD, and Amar Dixit, MD, senior and junior representatives of ACAAI's Fellows-In-Training (FITs) to the Board of Regents. The FIT Board Review Corner is an opportunity to help hone your Board preparedness. Review Questions Allergy and Immunology Review Corner: Middleton s Allergy Principles and Practice, 8th Edition N. Franklin Adkinson Jr., MD, Bruce S Bochner, MD, A Wesley Burks, MD, William W Busse, MD, Stephen T Holgate, MD, DSc, FMedSci, Robert F Lemanske, Jr., MD and Robyn E O'Hehir, FRACP, PhD, FRCPath Chapter 36 (pages ): Urticaria and angioedema Prepared by: Tammy Peng, MD 1. Which of the following characteristics are more consistent with urticarial vasculitis? a. Lesions are pruritic and raised in appearance. b. Lesions are painful, last longer than 48 hours and may leave purpura or ecchymosis. c. Lesions may be erythematous with central pallor. d. Lesions are more common in areas in which there is compression or friction of the skin. 2. Which condition is characterized by fever, urticarial and monoclonal gammopathy? a. Mastocytosis b. Cryoglobulinemia c. Muckle-Wells syndrome d. Schnitzler syndrome 3. Which of the following represents the most effective, first-line treatment for chronic urticaria? a. Second-generation H1 antihistamine (cetirizine, fexofenadine, loratadine) b. Corticosteroids c. H2 blocker d. First-generation H1 antihistamine (diphenhydramine, hydroxyzine) 4. Which of the following characteristics is typical of polymorphic eruption of pregnancy (PEP), also called pruritic urticarial papules and plaques of pregnancy (PUPPP)? a. Rash involves the face, palms and soles. b. Urticarial lesions that occur around the umbilicus. c. Lesions are triggered by pressure applied to the skin. d. Rash begins as papules within abdominal striae and spreads to involve the extremity.

2 Page 2 of 5 5. Which of the following histamine-release associated features is seen in a chronic idiopathic urticarial (CIU) responder? a. 10% of cellular histamine content is released to optimal dose of cross-linking anti-ige b. Syk same as or below normal c. Reduced SH2 domain-containing inositol 5-phosphatase (SHIP)-1 levels d. Tenfold higher dose response to anti-ige in active disease e. Increased SH2 domain-containing inositol 5-phosphatase (SHIP)-2 levels 6. Skin biopsy of a lesion demonstrating a predominance of neutrophils consistent with neutrophilic urticaria would be seen in which disease? a. Hereditary autoinflammatory fever syndromes b. Chronic idiopathic urticaria c. Aquagenic Urticaria d. Dermatographism 7. Which of the following is the most common cause of chronic urticaria? a. Food allergies b. Physical urticaria c. Idiopathic urticaria d. Malignancy 8. Which of the following medications that can be used as an alternative therapy in antihistamine refractory chronic urticarial is preferred in urticarial vasculitis, delayed pressure urticarial and angioedema? a. Sulfasalazine b. Dapsone c. Omalizumab d. Calcineurin inhibitors (cyclosporine, tacrolimus) 9. Which of the following systemic diseases associated with urticarial lesions involves a mutation in cryopyrin? a. Mastocytosis b. Cryoglobulinemia c. Familial cold autoinflammatory syndrome d. Muckle-Wells syndrome

3 Page 3 of A 42-year-old woman presents to clinic with a two-month history of recurrent, pruritic rash. She reports that the rash usually develops in the evening often under the waistband of her pants. She also notes that she often has this same itchy rash on her shoulder after carrying her purse around for a few hours. What type of physical urticaria is most consistent with this patient s history? a. Cholinergic urticaria b. Pressure-related urticaria c. Solar urticaria d. Vibratory urticaria

4 Page 4 of 5 Answers 1. B, pages 579 & 582. Skin lesions that are painful, that last more than 48 hours and that leave residual skin changes including ecchymosis are more suspicious for urticarial vasculitis. Eliciting a history with the presence of such lesions should prompt consideration for skin biopsy. 2. D, page 582. Schnitzler syndrome is a rare systemic disorder in patients with monoclonal IgM or IgG (monoclonal gammopathy). Patients have associated symptoms of fever, weight loss, bone pain, adenopathy and urticaria thought to be secondary circulating immune complexes and complement activation. 3. A, page 582. The most effective, first-line therapy for chronic urticarial is the use of new-generation antihistamines which include fexofenadine, loratadine and cetirizine. These medications are nonsedating, alleviate pruritus and reduce occurrence of wheals. Other options if these agents are only partial effective, one can consider 1) increasing the dose of the nonsedating antihistamine 2) addition of a sedating, oldergeneration antihistamine (diphenhydramine, hydroxyzine) 3) addition of H2 blocker 4) trial of a leukotriene pathway inhibitor. 4. D, page 583. Polymorphic eruption of pregnancy (PEP), also called pruritic urticarial papules and plaques of pregnancy (PUPPP) is a pruritic dermatitis that affects pregnant women. Typically, dermatitis begins as erythematous papules within abdominal striae with periumbilical sparing that then spread to the extremities and coalesce into urticarial plaques. Lesions can be target-like and usually spare the face, palms and soles. Of note, because of limited safety data, only loratadine and cetirizine are currently recommended for use in pregnancy. 5. C, page 579, table Blood basophil IgE receptor responses in patients with chronic idiopathic urticarial (CIU) have been divided into two basophil phenotypes CIU responders and CIU nonresponders. CIU nonresponder basophils do not degranulate to ex vivo IgE receptor activation and have elevated levels of IgE receptor regulating inhibitor phosphatases, SHIP-1 and SHIP-2. These two phenotypes are independent of autoimmune serum factor and reflect some differences in clinical features. While underlying disease mechanisms are still unclear, available evidence supports basophil responsiveness relevance to urticarial pathogenesis. 6. A, page 576. Histopathologic examination of an urticarial lesion will show pervascular leukocyte infiltrate composed of lymphocytes, eosinophils, neutrophils, and basophils as well as mast cells that have degranulated in the dermis. Neutrophilic predominance on skin lesion biopsy should prompt for evaluation of associated systemic diseases including adult-onset Still disease, Schnitzler syndrome, systemic lupus erythematosus and the hereditary autoinflammatory fever syndromes.

5 Page 5 of 5 7. C, page 575. In 80% of cases of chronic urticaria where no external allergic cause or other disease process can be identified, the condition is called chronic idiopathic urticarial. Approximately 20% of patients with chronic urticaria have a reproducible physical trigger for their skin lesions (called physical urticarial). 8. B, page 582. There is limited evidence on use of dapsone in chronic urticaria, especially in neutrophilic urticarial. Dapsone is preferred in treatment of urticarial vasculitis, delayed pressure urticarial and angioedema. Patients on dapsone should be monitored for anemia, neuropathy and methemoglobinemia. Other treatments of chronic urticaria that serve as alternative to corticosteroids in antihistamine resistant cases include sulfasalazine, hydroxychloroquine, calcineurin inhibitors, mycophenolate and omalizumab. 9. D, page 582. Muckle-Wells syndrome is associated with mutations in cryopyrin. Patients often have sensorineural hearing loss and are similar to patients with familial cold autoinflammatory syndrome, with the exception that patients are not cold-sensitive. Patients with familial cold autoinflammatory syndrome often present in infancy with symptoms including periodic fever, urticaria, leukocytosis, conjunctivitis and muscle and skin tenderness after exposure to cold. 10. B, page 583, table There are two described forms of pressure-related physical urticarial/angioedema. In the first form, urticarial develops shortly after pressure is applied to the skin, similarly to dermatographism. A second delayed-onset form appears several hours after at the site of pressure (in our patient s example, under the waistband of her pants or under the strap of her purse). Skin biopsies from patients with delayed-onset urticarial demonstrate both neutrophils and eosinophils.

Middleton Chapter 42b (pages ): Allergic and Nonallergic Rhinitis Prepared by: Tammy Peng, MD

Middleton Chapter 42b (pages ): Allergic and Nonallergic Rhinitis Prepared by: Tammy Peng, MD FIT Board Review Corner November 2017 Welcome to the FIT Board Review Corner, prepared by Amar Dixit, MD, and Christin L. Deal, MD, senior and junior representatives of ACAAI's Fellows-In- Training (FITs)

More information

Middleton Chapter 43 (pages ) Rhinosinusitis and Nasal Polyps Prepared by: Malika Gupta, MD

Middleton Chapter 43 (pages ) Rhinosinusitis and Nasal Polyps Prepared by: Malika Gupta, MD FIT Board Review Corner December 2017 Welcome to the FIT Board Review Corner, prepared by Amar Dixit, MD, and Christin L. Deal, MD, senior and junior representatives of ACAAI's Fellows-In- Training (FITs)

More information

How to Successfully Manage Chronic Urticaria? & Tall Tales from Texas

How to Successfully Manage Chronic Urticaria? & Tall Tales from Texas How to Successfully Manage Chronic Urticaria? & Tall Tales from Texas David A. Khan, MD Professor of Medicine and Pediatrics Allergy & Immunology Program Director 1 Disclosures Honoraria/Speakers Bureau

More information

Urticaria. Appearance. Epidemiology [1] Aetiology [2]

Urticaria. Appearance. Epidemiology [1] Aetiology [2] Page 1 of 5 View this article online at: patient.info/doctor/urticaria-pro Urticaria Urticaria, otherwise known as hives, is an itchy red blotchy rash resulting from swelling of the superficial part of

More information

They re Scratching and You re Scratching Your Head: An Approach to the Diagnosis and Management of Acute and Chronic Urticaria

They re Scratching and You re Scratching Your Head: An Approach to the Diagnosis and Management of Acute and Chronic Urticaria They re Scratching and You re Scratching Your Head: An Approach to the Diagnosis and Management of Acute and Chronic Urticaria Adelle R. Atkinson, MD, FRCPC Sea Courses May/June 2017 Copyright 2017 by

More information

4/12/18. Refractory Chronic Urticaria: When Omalizumab Fails. Objectives. Disclosures

4/12/18. Refractory Chronic Urticaria: When Omalizumab Fails. Objectives. Disclosures Refractory Chronic Urticaria: When Omalizumab Fails David A. Khan, MD Professor of Medicine and Pediatrics Allergy & Immunology Program Director 1 Disclosures n Research Grants n NIH n Honoraria n UpToDate,

More information

Managing urticaria in primary care

Managing urticaria in primary care Managing urticaria in primary care Tidman MJ. Managing urticaria in primary care. Practitioner 2015;259(1779)25-28 Dr Michael J. Tidman MD FRCP (Ed) FRCP (Lond) Consultant Dermatologist, Department of

More information

PedsCases Podcast Scripts

PedsCases Podcast Scripts PedsCases Podcast Scripts This is a text version of a podcast from Pedscases.com on Urticaria These podcasts are designed to give medical students an overview of key topics in pediatrics. The audio versions

More information

Update on urticaria Associate Professor Rohan Ameratunga Adapted for New Zealand from GLORIA Module 12: Urticaria

Update on urticaria Associate Professor Rohan Ameratunga Adapted for New Zealand from GLORIA Module 12: Urticaria Update on urticaria Associate Professor Rohan Ameratunga Adapted for New Zealand from GLORIA Module 12: Urticaria an educational program of Following this presentation you should be able to: Distinguish

More information

Chapter 65 Allergy and Immunology for the Internist. ingestion provoke an IgE antibody response and clinical symptoms in sensitive individuals.

Chapter 65 Allergy and Immunology for the Internist. ingestion provoke an IgE antibody response and clinical symptoms in sensitive individuals. Chapter 65 Allergy and Immunology for the Internist 1 I. Basic Information A. Definition of Allergens: Proteins of appropriate size that after inhalation, injection (e.g. drug, venom) or ingestion provoke

More information

Do My Patient s Hives Always = Allergy? Julie Sterbank, DO Allergy & Immunology MetroHealth Medical Center

Do My Patient s Hives Always = Allergy? Julie Sterbank, DO Allergy & Immunology MetroHealth Medical Center Do My Patient s Hives Always = Allergy? Julie Sterbank, DO Allergy & Immunology MetroHealth Medical Center I do not have any financial or conflicts of interest to make regarding any of the items or conditions

More information

Urticaria and Angioedema

Urticaria and Angioedema Urticaria and Angioedema This guideline, developed by Robbie Pesek, MD and Allison Burbank, MD, in collaboration with the ANGELS team, on July 23, 2013, is a significantly revised version of the guideline

More information

COMMISSIONING POLICY RECOMMENDATION TREATMENT ADVISORY GROUP Policy agreed by North Lincolnshire CCG November 2012

COMMISSIONING POLICY RECOMMENDATION TREATMENT ADVISORY GROUP Policy agreed by North Lincolnshire CCG November 2012 Drug, Treatment, Device name Omalizumab (Xolair; Novartis) COMMISSIONING POLICY RECOMMENDATION TREATMENT ADVISORY GROUP Policy agreed by North Lincolnshire CCG November 2012 Licensed indication Omalizumab

More information

Agroup as large as 15% to 24% of

Agroup as large as 15% to 24% of Update on Chronic Urticaria and Angioedema Sarbjit S. Saini, MD ABSTRACT PURPOSE: To review the various subtypes of angioedema and urticaria and their current standards of treatment and to highlight new

More information

CHRONIC URTICARIA; IT S MORE THAN JUST ANTIHISTAMINES!

CHRONIC URTICARIA; IT S MORE THAN JUST ANTIHISTAMINES! CHRONIC URTICARIA; IT S MORE THAN JUST ANTIHISTAMINES! Randy D. Danielsen, PhD, PA, DFAAPA Dean & Professor Arizona School of Health Sciences A.T. Still University Ûr tĭ-kâr ē-ә Urticaria is characterized

More information

Mast Cell Mediators. Updates on Chronic Urticaria 11/1/2016. Urticaria: What happens in the skin?

Mast Cell Mediators. Updates on Chronic Urticaria 11/1/2016. Urticaria: What happens in the skin? Urticaria: What happens in the skin? Updates on Chronic Urticaria Kent Woo, MD (USA) Allergy/Immunology Internal Medicine C A U S E MC, mast cell IgE Fc eri MC Release of Mediators Activation Vasodilation

More information

Perspectives in Primary Care: Evaluating and Managing Patients With Chronic Urticaria

Perspectives in Primary Care: Evaluating and Managing Patients With Chronic Urticaria Perspectives in Primary Care: Evaluating and Managing Patients With Chronic Urticaria Please complete the preassessment located in your meeting handout before the program begins. Sponsorship and Support

More information

Urticaria. An Evidence-Based Approach to Diagnosis & Management. July 16, 2015 Walter E. Washington Convention Center. Educational partner RMEI, LLC

Urticaria. An Evidence-Based Approach to Diagnosis & Management. July 16, 2015 Walter E. Washington Convention Center. Educational partner RMEI, LLC Urticaria An Evidence-Based Approach to Diagnosis & Management July 16, 2015 Walter E. Washington Convention Center Educational partner RMEI, LLC Session 8: Urticaria: An Evidence-Based Approach to Diagnosis

More information

Department of Paediatrics Clinical Guideline URTICARIA GUIDELINE BACKGROUND

Department of Paediatrics Clinical Guideline URTICARIA GUIDELINE BACKGROUND Department of Paediatrics Clinical Guideline URTICARIA GUIDELINE BACKGROUND This guideline is intended for use in A&E and general paediatric OPD to assist with the management of initial presentations of

More information

--Manuscript Draft-- World Allergy Organization Position Paper (Provisional) Centro Medico-Docente La Trinidad Caracas, Miranda VENEZUELA

--Manuscript Draft-- World Allergy Organization Position Paper (Provisional) Centro Medico-Docente La Trinidad Caracas, Miranda VENEZUELA World Allergy Organization Journal Diagnosis and Treatment of Urticaria and Angioedema, A Worldwide Perspective: World Allergy Organization Position Paper (Provisional) --Manuscript Draft-- Manuscript

More information

We are IntechOpen, the first native scientific publisher of Open Access books. International authors and editors. Our authors are among the TOP 1%

We are IntechOpen, the first native scientific publisher of Open Access books. International authors and editors. Our authors are among the TOP 1% We are IntechOpen, the first native scientific publisher of Open Access books 3,350 108,000 1.7 M Open access books available International authors and editors Downloads Our authors are among the 151 Countries

More information

The proposal is to add text/statements in red and to delete text/statements with strikethrough: POLICY

The proposal is to add text/statements in red and to delete text/statements with strikethrough: POLICY Omalizumab DESCRIPTION Omalizumab is a recombinant DNA-derived humanized IgG1κ monoclonal antibody which selectively binds to immunoglobulin E (IgE). High serum levels of IgE are found in individuals with

More information

Itch and Swelling update: Practical Approach to Urticaria & Angioedema

Itch and Swelling update: Practical Approach to Urticaria & Angioedema Itch and Swelling update: Practical Approach to Urticaria & Angioedema Robert W Hostoffer, DO, LhD, FAAP, FACOP, FACOI, FCCP Program Director, Allergy/Immunology Fellowship Neha Sanan, DO Allergy & Immunology

More information

Perspectives in Primary Care: Evaluating and Managing Patients with Chronic Urticaria

Perspectives in Primary Care: Evaluating and Managing Patients with Chronic Urticaria Saturday General Session Perspectives in Primary Care: Evaluating and Managing Patients with Chronic Urticaria Anne Marie Ditto, MD Associate Professor of Medicine Division of Allergy Immunology Northwestern

More information

REFERRAL GUIDELINES - SUMMARY

REFERRAL GUIDELINES - SUMMARY Clinical Immunology & Allergy Unit LEEDS TEACHING HOSPITALS NHS TRUST REFERRAL GUIDELINES - SUMMARY THESE GUIDELINES ARE DESIGNED TO ENSURE THAT PATIENTS REQUIRING SECONDARY CARE ARE SEEN EFFICIENTLY AND

More information

Annual Rheumatology & Therapeutics Review for Organizations & Societies

Annual Rheumatology & Therapeutics Review for Organizations & Societies Annual Rheumatology & Therapeutics Review for Organizations & Societies Update on Granulomatosis with Polyangiitis (Wegener s) Philip Seo, MD, MHS Director, Johns Hopkins Vasculitis Center Director, Johns

More information

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Single Technology Appraisal (STA)

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Single Technology Appraisal (STA) Thank you for agreeing to give us a statement on your organisation s view of the technology and the way it should be used in the NHS. Healthcare professionals can provide a unique perspective on the technology

More information

Allergy Medicine James MacLean, M.D.

Allergy Medicine James MacLean, M.D. Allergy Medicine 2018 James MacLean, M.D. Conflict of Interest Disclosures James A MacLean, MD FACAAI, FAAAAI None Objectives Identify the major causes of acute and chronic urticaria and angioedema Review

More information

Urticaria and Angioedema. Allergy and Immunology Awareness Program

Urticaria and Angioedema. Allergy and Immunology Awareness Program Urticaria and Angioedema Allergy and Immunology Awareness Program 1 Urticaria and Angioedema Allergy and Immunology Awareness Program Urticaria Commonly known as hives, urticarial is an itchy rash with

More information

Allergy Medicine James MacLean, M.D.

Allergy Medicine James MacLean, M.D. Allergy Medicine 2019 James MacLean, M.D. Conflict of Interest Disclosures James A MacLean, MD FACAAI, FAAAAI None Objectives Identify the major causes of acute and chronic urticaria and angioedema Review

More information

Diagnosis and Treatment of Urticaria and Angioedema: A Worldwide Perspective

Diagnosis and Treatment of Urticaria and Angioedema: A Worldwide Perspective WAO POSITION PAPER Diagnosis and Treatment of Urticaria and Angioedema: A Worldwide Perspective Mario Sánchez-Borges, MD, 1 Riccardo Asero, MD, 2 Ignacio J. Ansotegui, MD, 3 Ilaria Baiardini, MD, 4 Jonathan

More information

xx Xolair 150 MG SOLR (GENENTECH)

xx Xolair 150 MG SOLR (GENENTECH) Omalizumab NDC CODE(S) 50242-0040-xx Xolair 150 MG SOLR (GENENTECH) DESCRIPTION Omalizumab is a recombinant DNA-derived humanized IgG1κ monoclonal antibody which selectively binds to immunoglobulin E (IgE).

More information

Acute and Chronic Urticaria, Including New Treatment Options

Acute and Chronic Urticaria, Including New Treatment Options Acute and Chronic Urticaria, Including New Treatment Options Charles V. Klucka, D.O. Florida Osteopathic Medical Association, District XI October 19, 2018 Disclosures I have no relevant financial relationships

More information

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND BIO-SCIENCE

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND BIO-SCIENCE Gajbhiye S,, 2014; Volume 3(4): 686-694 INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND BIO-SCIENCE CHOLINERGIC URTICARIA: A REVIEW FROM PATHOPHYSIOLOGY, SYMPTOMS, SUBTYPES, DIAGNOSIS TO TREATMENT

More information

Topic 9 (Ch16_18) Immune Disorders. Allergies. 4 Hypersensitivity Types. Topics - Allergies - Autoimmunity - Immunodeficiency

Topic 9 (Ch16_18) Immune Disorders. Allergies. 4 Hypersensitivity Types. Topics - Allergies - Autoimmunity - Immunodeficiency Topic 9 (Ch16_18) Immune Disorders Topics - Allergies - Autoimmunity - Immunodeficiency 1 Allergies Allergens (antigens) cause an exaggerated immune response or hypersensitivity 4 types: Type I Type II

More information

Current Concepts in the Pathogenesis and Management of Urticaria and Angioedema:

Current Concepts in the Pathogenesis and Management of Urticaria and Angioedema: Bahrain Medical Bulletin, Vol. 27, No. 2, June 2005 Current Concepts in the Pathogenesis and Management of Urticaria and Angioedema: Mirghani A E Uthman, Ph.D* Definitions Urticaria is characterized by

More information

Familial atypical cold urticaria: Description of a new hereditary disease

Familial atypical cold urticaria: Description of a new hereditary disease Familial atypical cold urticaria: Description of a new hereditary disease Chhavi Gandhi, MD, a Chris Healy, MD, b Alan A. Wanderer, MD, c and Hal M. Hoffman, MD a,d,e Bozeman, Mont, and San Diego, Calif

More information

=ﻰﻤاﻤﺤﻠا ﺔﻴﻘﻠﺤﻠا ﺔذﺒاﻨﻠا

=ﻰﻤاﻤﺤﻠا ﺔﻴﻘﻠﺤﻠا ﺔذﺒاﻨﻠا 1 / 15 Erythema Annulare Centrifugum and Other Figurate Erythemas The figurate erythemas include a variety of eruptions characterized by annular and polycyclic lesions. Classification of this group has

More information

Hypersensitivity is the term used when an immune response results in exaggerated or inappropriate reactions harmful to the host.

Hypersensitivity is the term used when an immune response results in exaggerated or inappropriate reactions harmful to the host. Hypersensitivity is the term used when an immune response results in exaggerated or inappropriate reactions harmful to the host. Hypersensitivity vs. allergy Hypersensitivity reactions require a pre-sensitized

More information

Sporadic Antihistamine-Resistant Angioedema Potential Pathophysiological Mechanisms

Sporadic Antihistamine-Resistant Angioedema Potential Pathophysiological Mechanisms Sporadic Antihistamine-Resistant Angioedema Potential Pathophysiological Mechanisms Massimo Triggiani, MD, PhD Division of Allergy and Clinical Immunology University of Salerno HAWK Consensus Meeting Gargnano,

More information

What the first 10,000 patients with chronic urticaria have taught me: A personal journey

What the first 10,000 patients with chronic urticaria have taught me: A personal journey Clinical pearls What the first 10,000 patients with chronic urticaria have taught me: A personal journey Allen P. Kaplan, MD Charleston, SC Key words: Urticaria, angioedema, histamine, antihistamine, corticosteroids,

More information

2012/12/5. Principle of the management of urticaria. The efficacy of systemic steroid on urticaria depends of subtypes urticaria

2012/12/5. Principle of the management of urticaria. The efficacy of systemic steroid on urticaria depends of subtypes urticaria 6 December 2012: 13:3015:00 G.04 (HICC) The Hyderabad International Convention Centre (HICC) in Hyderabad, India WISC 2012; WAO International Scientific Conference Postgraduate Course 16: URTICARIA & ANGIOEDEMA

More information

Anaphylaxis: The Atypical Varieties

Anaphylaxis: The Atypical Varieties Anaphylaxis: The Atypical Varieties John Johnson, D.O., PGY-4 Allergy/Immunology Fellow University Hospitals of Cleveland Case Western Reserve University School of Medicine Disclosures: None What is Anaphylaxis?

More information

Treatment Options for Refractory Urticaria

Treatment Options for Refractory Urticaria Treatment Options for Refractory Urticaria David A. Khan, MD Professor of Medicine Allergy & Immunology Program Director Division of Allergy & Immunology University of Texas Southwestern Medical Center

More information

Xolair. Xolair (omalizumab) Description

Xolair. Xolair (omalizumab) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.45.02 Subject: Xolair Page: 1 of 6 Last Review Date: March 18, 2016 Xolair Description Xolair (omalizumab)

More information

Xolair. Xolair (omalizumab) Description

Xolair. Xolair (omalizumab) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.45.02 Subject: Xolair Page: 1 of 7 Last Review Date: September 15, 2016 Xolair Description Xolair (omalizumab)

More information

Disclosures. Objectives 1/27/13. Pinkus Goldberg MD, FAAAAI, FAACAI, CPI Karen Rance DNP, RN, CPNP, AE-C. Allergy Partners of Central Indiana

Disclosures. Objectives 1/27/13. Pinkus Goldberg MD, FAAAAI, FAACAI, CPI Karen Rance DNP, RN, CPNP, AE-C. Allergy Partners of Central Indiana Pinkus Goldberg MD, FAAAAI, FAACAI, CPI Karen Rance DNP, RN, CPNP, AE-C Allergy Partners of Central Indiana Disclosures Dr. Goldberg is a speaker for Merck, Mylan, Meda, Genetech and conducts research

More information

Allergy & Urticaria. James MacLean, M.D.

Allergy & Urticaria. James MacLean, M.D. Allergy & Urticaria James MacLean, M.D. Conflict of Interest Disclosures James A MacLean, MD FACAAI, FAAAAI None Objectives Upon completion of this lecture the participant should be able to: Identify the

More information

Cigna Drug and Biologic Coverage Policy

Cigna Drug and Biologic Coverage Policy Cigna Drug and Biologic Coverage Policy Subject Omalizumab Table of Contents Coverage Policy... 1 General Background... 4 Coding/Billing Information... 6 References... 7 Effective Date... 3/15/2018 Next

More information

Clinical and Experimental Allergy

Clinical and Experimental Allergy doi: 10.1111/j.1365-2222.2007.02678.x Clinical and Experimental Allergy, 37, 631 650 Journal compilation c 2007 Blackwell Publishing Ltd SPECIAL ARTICLE BSACI guidelines for the management of chronic urticaria

More information

Allergic Conditions in Sports. Seth Smith, MD, CAQ-SM, PharmD TPC Course February 7, 2016

Allergic Conditions in Sports. Seth Smith, MD, CAQ-SM, PharmD TPC Course February 7, 2016 Allergic Conditions in Sports Seth Smith, MD, CAQ-SM, PharmD TPC Course February 7, 2016 Goals and Objectives Describe diagnosis and management of exercise-induced bronchospasm/bronchoconstriction (EIB)

More information

How to Treat PULL-OUT SECTION www.australiandoctor.com.au Complete How to Treat quizzes online (www.australiandoctor.com.au/cpd) to earn CPD or PDP points. inside Classification Clinical manifestations

More information

Evaluation, diagnosis and management of chronic urticaria

Evaluation, diagnosis and management of chronic urticaria Evaluation, diagnosis and management of chronic urticaria Author Perera, Eshini, Sinclair, Rodney Published 2014 Journal Title Australian Family Physician Copyright Statement 2014 Australian Family Physician.

More information

Managing Penicillin Allergy

Managing Penicillin Allergy Managing Penicillin Allergy Brian T. Kelly, MD MA April 12, 2019 Objectives Review penicillin allergy prevalence, morbidity, and management Describe the penicillin testing and oral challenge process Provide

More information

The management of chronic urticaria in primary care for adults and children

The management of chronic urticaria in primary care for adults and children The management of chronic urticaria in primary care for adults and children September Version 2.0 This supersedes version 1.0 Review due in September 2019 Document location DOCUMENT CONTROL Copies of this

More information

TREATMENT OF ALLERGIC SKIN DISEASES

TREATMENT OF ALLERGIC SKIN DISEASES TREATMENT OF ALLERGIC SKIN DISEASES Prof. Dr.Oktay Taskapan, MD Professor of Dermatology & Allergic Diseases GATA School of Medicine, Haydarpasa Teaching Hospital, Department of Medicine, Section of Allergy,

More information

Clinico - etiological study of chronic Urticaria and the role of autologous serum skin test in the diagnosis of chronic idiopathic Urticaria

Clinico - etiological study of chronic Urticaria and the role of autologous serum skin test in the diagnosis of chronic idiopathic Urticaria Original Article Clinico etiological study of chronic Urticaria and the role of autologous serum skin test in the diagnosis of chronic idiopathic Urticaria Swetha D, M Bhagya Rekha, S Srikanth, B.S.N.Reddy

More information

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Medical Policy An independent licensee of the Blue Cross Blue Shield Association Xolair (omalizumab) Page 1 of 15 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Xolair (omalizumab) Prime Therapeutics will review Prior Authorization requests.

More information

Autoimmunity and autoinflammation

Autoimmunity and autoinflammation Autoimmunity and autoinflammation Primary immunodeficiencies Autoimmunity and autoinflammation 1 Primary immunodeficiencies List of some common abbreviations APECED CAPS CGD CINCA CRMO CVID FCAS FMF HIDS

More information

Chronic urticaria (CU) is a debilitating skin condition

Chronic urticaria (CU) is a debilitating skin condition Retrospective analysis of the efficacy of omalizumab in chronic refractory urticaria Ravi K. Viswanathan, M.D., Mark H. Moss, M.D., and Sameer K. Mathur, M.D., Ph.D. ABSTRACT Omalizumab has been shown

More information

Clinical Policy Title: Omalizumab for the treatment of chronic idiopathic urticaria

Clinical Policy Title: Omalizumab for the treatment of chronic idiopathic urticaria Clinical Policy Title: Omalizumab for the treatment of chronic idiopathic urticaria Clinical Policy Number: 18.02.07 Effective Date: April 1, 2016 Initial Review Date: January 20, 2016 Most Recent Review

More information

Allergic rhinitis (Hay fever) Asthma Anaphylaxis Urticaria Atopic dermatitis

Allergic rhinitis (Hay fever) Asthma Anaphylaxis Urticaria Atopic dermatitis Hypersensitivity Disorders Hypersensitivity Disorders Immune Response IgE Disease Example Ragweed hay fever IgG Cytotoxic Immune complex T Cell Hemolytic anemia Serum sickness Poison ivy IgE-mediated Diseases

More information

3302: Therapy Options for Patients with Anti-Histamine Resistant Chronic Urticaria

3302: Therapy Options for Patients with Anti-Histamine Resistant Chronic Urticaria 3302: Therapy Options for Patients with Anti-Histamine Resistant Chronic Urticaria Javed Sheikh, M.D. FAAAI Department of Allergy & Clinical Immunology Kaiser Permanente Los Angeles Medical Center Disclosure

More information

Xolair (Omalizumab) Drug Prior Authorization Protocol (Medical Benefit & Part B Benefit)

Xolair (Omalizumab) Drug Prior Authorization Protocol (Medical Benefit & Part B Benefit) Line of Business: All Lines of Business Effective Date: August 16, 2017 Xolair (Omalizumab) Drug Prior Authorization Protocol (Medical Benefit & Part B Benefit) This policy has been developed through review

More information

Drug allergy and Skin Disorders. Timothy Craig, DO, FACOI Professor of Medicine and Pediatrics Distinguished Educator Penn State University, Hershey

Drug allergy and Skin Disorders. Timothy Craig, DO, FACOI Professor of Medicine and Pediatrics Distinguished Educator Penn State University, Hershey Drug allergy and Skin Disorders Timothy Craig, DO, FACOI Professor of Medicine and Pediatrics Distinguished Educator Penn State University, Hershey The best screening test for anaphylaxis is? A. histamine

More information

Coverage Criteria: Express Scripts, Inc. monograph dated 03/03/2010

Coverage Criteria: Express Scripts, Inc. monograph dated 03/03/2010 BENEFIT DESCRIPTION AND LIMITATIONS OF COVERAGE ITEM: PRODUCT LINES: COVERED UNDER: DESCRIPTION: CPT/HCPCS Code: Company Supplying: Setting: Xolair (omalizumab) Commercial HMO/PPO/CDHP HMO/PPO/CDHP: Rx

More information

Allergy and inflammation

Allergy and inflammation and inflammation 1 Allergic population hyper-producers of IgE consistently increasing western societies: ~20% of general population 2 Allergic population 3 Allergic triggers 4 Allergic triggers abnormal

More information

Lecture 03: Drug allergy

Lecture 03: Drug allergy Lecture 03: Drug allergy 1. Basic Information Author: Netherlands Pharmacovigilance Centre Lareb Version date: 17 Nov 2017 Content: This hand-out describes Drug allergy and provides background information

More information

URTICARIA. Roundtable session

URTICARIA. Roundtable session URTICARIA Roundtable session Common Referral Pitfalls All urticaria is allergic All angioedema is a prelude to anaphylaxis All peri-orbital swelling is angioedema Patch testing referrals for urticaria

More information

Idiopathic U rticaria U Urticaria Diffuse Giant Hives

Idiopathic U rticaria U Urticaria Diffuse Giant Hives Chronic Urticaria and Angioedema in Adults Selected Topics in Internal Medicine Review Course Internal Medicine Department University of Puerto Rico School of Medicine Fernando J Lopez-Malpica Malpica,

More information

Pharmacotherapy for Allergic Rhinitis

Pharmacotherapy for Allergic Rhinitis Pharmacotherapy for Allergic Rhinitis William Reisacher, MD FACS FAAOA Assistant Professor Weill Cornell Medical College The Impact of Allergic Rhinitis Allergic rhinitis affects approximately 50 million

More information

Path2220 INTRODUCTION TO HUMAN DISEASE ALLERGY. Dr. Erika Bosio

Path2220 INTRODUCTION TO HUMAN DISEASE ALLERGY. Dr. Erika Bosio Path2220 INTRODUCTION TO HUMAN DISEASE ALLERGY Dr. Erika Bosio Research Fellow Centre for Clinical Research in Emergency Medicine, Harry Perkins Institute of Medical Research University of Western Australia

More information

Autologous serum skin test versus histamine release test in the diagnosis of Chronic autoimmune urticaria

Autologous serum skin test versus histamine release test in the diagnosis of Chronic autoimmune urticaria ORIGINAL ARTICLE Autologous serum skin test versus histamine release test in the diagnosis of Chronic autoimmune urticaria Al-Sadat Mosbeh, 1 MD, Ibrahim G. Ramadan, 2 MD, Abdelaleem Elgendy, 3 MD 1 Department

More information

Acute urticaria in children - management. Clive Grattan St John s Institute of Dermatology, London Norfolk & Norwich University Hospital

Acute urticaria in children - management. Clive Grattan St John s Institute of Dermatology, London Norfolk & Norwich University Hospital Acute urticaria in children - management Clive Grattan St John s Institute of Dermatology, London Norfolk & Norwich University Hospital Scope of my talk What is acute urticaria? Who, why, when and where?

More information

Omalizumab (Xolair) NHLBI normal ranges by age for FEV 1/FVC 8-19 years of age 85%; years of age 80%;

Omalizumab (Xolair) NHLBI normal ranges by age for FEV 1/FVC 8-19 years of age 85%; years of age 80%; DRAFT Medical Coverage Policy Injectable Agents for Asthma and Chronic Idiopathic Urticaria Fasenra, Nucala, Xolair, Cinqair EFFECTIVE DATE: 03 01 2018 POLICY LAST UPDATED: 03 20 2018 OVERVIEW This policy

More information

Management of Chronic Idiopathic Urticaria

Management of Chronic Idiopathic Urticaria 9/3/216 Management of Chronic Idiopathic Urticaria Brian Berman, M.D., Ph.D. Professor Emeritus of Dermatology and Dermatologic Surgery, University of Miami Co-Director Center for Clinical and Cosmetic

More information

Management of urticaria: Iranian Society of Dermatology clinical practice guideline

Management of urticaria: Iranian Society of Dermatology clinical practice guideline Original Article Management of urticaria: Iranian Society of Dermatology clinical practice guideline Alireza Firooz, MD 1,2 Zahra Hallaji, MD 3,4 Alireza Khatami, MD, MSc(PH), MScMedEd 1 Vahideh Lajevardi,

More information

Chapter 10 (pages ): Differentiation and Functions of CD4+ Effector T Cells Prepared by Kristen Dazy, MD, Scripps Clinic Medical Group

Chapter 10 (pages ): Differentiation and Functions of CD4+ Effector T Cells Prepared by Kristen Dazy, MD, Scripps Clinic Medical Group FIT Board Review Corner September 2015 Welcome to the FIT Board Review Corner, prepared by Andrew Nickels, MD, and Sarah Spriet, DO, senior and junior representatives of ACAAI's Fellows-In-Training (FITs)

More information

Questions. Answers. Share your photos and diagnoses with us!

Questions. Answers. Share your photos and diagnoses with us! Illustrated quizzes on problems seen in everyday practice CASE 1 A 65-year-old man is noted to have a lazy, grey ring separated from the limbus with a clear interval in both eyes. 2. What is the significance?

More information

S003 CPC Self-Assessment

S003 CPC Self-Assessment S003 CPC Self-Assessment Alina G. Bridges, D.O. Associate Professor Program Director, Dermatopathology Fellowship Department of Dermatology, Division of Dermatopathology and Cutaneous Immunopathology Mayo

More information

CHRONIC URTICARIA IN CHILDREN: A REVIEW

CHRONIC URTICARIA IN CHILDREN: A REVIEW CHRONIC URTICARIA IN CHILDREN: A REVIEW *Blanca R. Del Pozzo-Magaña Department of Pediatrics, Children s Hospital of Western Ontario, London, Canada *Correspondence to brdelpozzo@gmail.com Disclosure:

More information

Immunology. Lecture- 8

Immunology. Lecture- 8 Immunology Lecture- 8 Immunological Disorders Immunodeficiency Autoimmune Disease Hypersensitivities Immunodeficiency 1. Immunodeficiency --> abnormal production or function of immune cells, phagocytes,

More information

XOLAIR (omalizumab) Prior Authorization

XOLAIR (omalizumab) Prior Authorization MP9309 Covered Service: Prior Authorization Required: Additional Information: Yes when meets criteria below Yes as shown below May only be prescribed by Allergy, Pulmonary, Immunology or Dermatology specialists

More information

CPC. Chutika Srisuttiyakorn, M.D. Kobkul Aunhachoke, M.D. Phramongkutklao Hospital Bangkok, Thailand

CPC. Chutika Srisuttiyakorn, M.D. Kobkul Aunhachoke, M.D. Phramongkutklao Hospital Bangkok, Thailand CPC Chutika Srisuttiyakorn, M.D. Kobkul Aunhachoke, M.D. Phramongkutklao Hospital Bangkok, Thailand A 53 year-old woman with fever, facial swelling and rashes on face, trunk and upper extremities for 3

More information

Urticaria: The final common pathway

Urticaria: The final common pathway Allergology International (1996) 45: 171-176 Review Article Urticaria: The final common pathway C Warren Bierman Department of Pediatrics, University of Washington, Seattle, Washington, USA ABSTRACT Urticaria

More information

PedsCases Podcast Scripts

PedsCases Podcast Scripts PedsCases Podcast Scripts This is a text version of a podcast from Pedscases.com on Drug Allergy. These podcasts are designed to give medical students an overview of key topics in pediatrics. The audio

More information

ALLERGIC RHINOSINUSITIS. Sirisha A Post graduate Dept of Pharmacology Kamineni Institute of Medical Sciences

ALLERGIC RHINOSINUSITIS. Sirisha A Post graduate Dept of Pharmacology Kamineni Institute of Medical Sciences ALLERGIC RHINOSINUSITIS Sirisha A Post graduate Dept of Pharmacology Kamineni Institute of Medical Sciences OVERVIEW Pathophysiology Goals of therapy Approaches to therapy Antihistaminics Corticosteroids

More information

How the Innate Immune System Profiles Pathogens

How the Innate Immune System Profiles Pathogens How the Innate Immune System Profiles Pathogens Receptors on macrophages, neutrophils, dendritic cells for bacteria and viruses Broad specificity - Two main groups of bacteria: gram positive, gram-negative

More information

Allergy overview. Mike Levin Division of Asthma and Allergy Department of Paediatrics University of Cape Town Red Cross Hospital

Allergy overview. Mike Levin Division of Asthma and Allergy Department of Paediatrics University of Cape Town Red Cross Hospital Allergy overview Mike Levin Division of Asthma and Allergy Department of Paediatrics University of Cape Town Red Cross Hospital Adaptive Immune Responses Adaptive immune responses allow responses against

More information

Itchy, Scratchy, Red and Patchy: Derm tips for primary care. Robert Gniadecki, MD

Itchy, Scratchy, Red and Patchy: Derm tips for primary care. Robert Gniadecki, MD Itchy, Scratchy, Red and Patchy: Derm tips for primary care Robert Gniadecki, MD Faculty/Presenter Disclosure Faculty: Robert Gniadecki Relationships with financial sponsors: Grants/Research Support: N/A

More information

While many people believe they may be allergic

While many people believe they may be allergic Focus on CME at the xxx University of Toronto The Truth Behind Allergies Peter Vadas, MD, PhD, FRCPC, FACP To be presented at the University of Toronto, Therapeutic Update, CME for Primary Care Today 2003,

More information

Pediatric Dermatology

Pediatric Dermatology Pediatric Dermatology --------- Emergencies & Urgencies Nicholas V. Nguyen, M.D. Director, Pediatric Dermatology Disclosures In the past 12 months, I have had the following financial relationships with

More information

Urticaria diagnosis and management

Urticaria diagnosis and management Urticaria diagnosis and management Susan Aquilina MD, FRCP (UK) Consultant Dermatologist, Department of Dermatology and Venereology, Sir Paul Boffa Hospital, Floriana, Malta Email: sue_aquilina@yahoo.com

More information

Immunologic Mechanisms of Tissue Damage. (Immuopathology)

Immunologic Mechanisms of Tissue Damage. (Immuopathology) Immunologic Mechanisms of Tissue Damage (Immuopathology) Immunopathology Exaggerated immune response may lead to different forms of tissue damage 1) An overactive immune response: produce more damage than

More information

Allergy and Immunology Review Corner: Chapter 57 of Middleton s Allergy Principles and Practice, 7 th Edition, edited by N. Franklin Adkinson, et al.

Allergy and Immunology Review Corner: Chapter 57 of Middleton s Allergy Principles and Practice, 7 th Edition, edited by N. Franklin Adkinson, et al. Allergy and Immunology Review Corner: Chapter 57 of Middleton s Allergy Principles and Practice, 7 th Edition, edited by N. Franklin Adkinson, et al. Chapter 57: Insect Allergy Pages 1005-1017 Prepared

More information

Allergy & Urticaria Workshop James MacLean, M.D.

Allergy & Urticaria Workshop James MacLean, M.D. Allergy & Urticaria Workshop 2018 James MacLean, M.D. Conflict of Interest Disclosures James A MacLean, MD FACAAI, FAAAAI None Objectives Upon completion of this lecture the participant should be able

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Shenoy E, Macy E, Rowe TA, Blumenthal KG. Evaluation and management of penicillin allergy. JAMA. doi:10.1001/jama.2018.19283 Table 1. Hypersensitivity reaction types Table

More information

Cutaneous Adverse Drug Reactions in Domestic Animals. Katherine Doerr, DVM, Dip. ACVD. Veterinary Dermatology Center

Cutaneous Adverse Drug Reactions in Domestic Animals. Katherine Doerr, DVM, Dip. ACVD. Veterinary Dermatology Center Cutaneous Adverse Drug Reactions in Domestic Animals Katherine Doerr, DVM, Dip. ACVD Veterinary Dermatology Center Maitland, Rockledge, Waterford Lakes, FL Not highly studied in veterinary medicine Unknown

More information

OBJECTIVES DEFINITION TYPE I HYPERSENSITIVITY TYPES OF HYPERSENSITIVITY ACUTE ALLERGIC REACTION 11/5/2016

OBJECTIVES DEFINITION TYPE I HYPERSENSITIVITY TYPES OF HYPERSENSITIVITY ACUTE ALLERGIC REACTION 11/5/2016 OBJECTIVES ACUTE ALLERGIC REACTION Wei Zhao, MD, PhD Ambulatory Medical Director Children s Hospital of Richmond at VCU Associate Professor, Chief Chief, Division of Allergy and Immunology Virginia Commonwealth

More information

Hien Nguyen Reeves, MD, ABAI, ABIM Clinical instructor UBC, Kelowna, BC

Hien Nguyen Reeves, MD, ABAI, ABIM Clinical instructor UBC, Kelowna, BC Hien Nguyen Reeves, MD, ABAI, ABIM Clinical instructor UBC, Kelowna, BC Disclosures Grants/Research Support: None Speakers Bureau/Honoraria: Pfizer Canada, CME Speaker Schering-Plough Merck Pictures Dermatology

More information